-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Armata Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2023.
- Armata Pharmaceuticals, Inc. Depreciation for the quarter ending June 30, 2024 was $300K, a 50% increase year-over-year.
- Armata Pharmaceuticals, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.2M, a 37.3% increase year-over-year.
- Armata Pharmaceuticals, Inc. annual Depreciation for 2023 was $1M, a 11.1% increase from 2022.
- Armata Pharmaceuticals, Inc. annual Depreciation for 2022 was $900K, a 23% decline from 2021.
- Armata Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.17M, a 4.94% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)